These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Picture of the month. Neurocysticercosis. Gerber JS; Shah SS Arch Pediatr Adolesc Med; 2006 Oct; 160(10):1081. PubMed ID: 17018470 [No Abstract] [Full Text] [Related]
29. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis. Jung-Cook H Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156 [TBL] [Abstract][Full Text] [Related]
30. Advances in the diagnosis and management of neurocysticercosis. Serpa JA; Yancey LS; White AC Expert Rev Anti Infect Ther; 2006 Dec; 4(6):1051-61. PubMed ID: 17181420 [TBL] [Abstract][Full Text] [Related]
36. Bioactive molecules of Taenia solium metacestode, a causative agent of neurocysticercosis. Bae YA; Xue Y; Lee EG; Kim SH; Kong Y Expert Rev Proteomics; 2010 Oct; 7(5):691-707. PubMed ID: 20973642 [TBL] [Abstract][Full Text] [Related]
37. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). Garcia HH; Del Brutto OH; Nash TE; White AC; Tsang VC; Gilman RH Am J Trop Med Hyg; 2005 Jan; 72(1):3-9. PubMed ID: 15728858 [TBL] [Abstract][Full Text] [Related]
38. Recent advancements and new perspectives in animal models for Neurocysticercosis immunopathogenesis. Arora N; Tripathi S; Kumar P; Mondal P; Mishra A; Prasad A Parasite Immunol; 2017 Jul; 39(7):. PubMed ID: 28467600 [TBL] [Abstract][Full Text] [Related]
39. Neurocysticercosis: updated concepts about an old disease. Garcia HH; Del Brutto OH; Lancet Neurol; 2005 Oct; 4(10):653-61. PubMed ID: 16168934 [TBL] [Abstract][Full Text] [Related]
40. Neurocysticercosis: a review on status in India, management, and current therapeutic interventions. Ahmad R; Khan T; Ahmad B; Misra A; Balapure AK Parasitol Res; 2017 Jan; 116(1):21-33. PubMed ID: 27774576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]